Loading
株式会社北里 Stock: price and insider trades · Japan
JP·Mcap JP¥57.3B
株式会社北里: what insiders have been doing
株式会社北里 has a thin disclosure history in our data (latest filing: 17 August 2026). New filings will appear here as soon as they are published. Every figure here comes from the filings published by EDINET (Japan FSA) and describes the past, not future prices; it is not investment advice.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 1,153 of 26,286 companies
79.7
score / 100
Value70
Quality90
FCF yld6.6%
Earn yld7.1%
EV/EBITDA9.0x
ROE22%
Gross mgn66%
Net mgn36%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
JP¥1,432
Analyst consensus
Income statement
RevenueJP¥10.9B
Gross profitJP¥7.2B66% margin
EBITDAJP¥6.1B56% margin
Net incomeJP¥3.9B36.1% margin
Valuation
PER (trailing)13.8x
P/Book2.9x
Balance sheet & cash
Market capJP¥57.3B
Free Cash FlowJP¥3.6B
Profitability & ownership
ROE22.3%
ROA19.6%
% insiders58.8%
% institutions29.8%
Last declaration on 17 August 2026
Declarations1 total
ShareXTKSEDINET:S100YX9U
1 of 1 declaration
About 株式会社北里
Kitasato Institute Co., Ltd. is a Japanese company listed on the XTKS market. It is involved in the health and life sciences sector.
